Parenteral development of clindamycin-2-phosphate.
D000818:Animals; D001702:Biopharmaceutics; D002981:Clindamycin / Q000097:blood; D004285:Dogs; D004304:Dosage Forms; D004339:Drug Compounding; D004355:Drug Stability; D007263:Infusions, Parenteral; D007700:Kinetics; D008034:Lincomycin
D004304:Dosage Forms; D002981:Clindamycin; D008034:Lincomycin